Howard Hughes Medical Institute’s TransDigm Group TDG Stock Holding History

Howard Hughes Medical Institute’s Portfolio TDG Stock Details TDG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-12	Closed	-$16K	–	425
2025 Q4	$16K	Hold	12	–	–	0.01%	142
2025 Q3	$15.8K	Hold	12	–	–	0.01%	143
2025 Q2	$18.2K	Buy	+12	New	+$16.9K	0.01%	119
2016 Q3	–	Sell	-1,658	Closed	-$437K	–	173
2016 Q2	$437K	Buy	1,658 +145	+10%	+$35.4K	0.15%	94
2016 Q1	$333K	Hold	1,513	–	–	0.07%	96
2015 Q4	$346K	Buy	1,513 +889	+142%	+$200K	0.05%	112
2015 Q3	$133K	Buy	+624	New	+$143K	0.02%	131
2014 Q2	–	Sell	-1,091	Closed	-$202K	–	228
2014 Q1	$202K	Buy	1,091 +167	+18%	+$29.2K	0.03%	84
2013 Q4	$149K	Sell	924 -143	-13%	-$21.3K	0.02%	107
2013 Q3	$148K	Buy	1,067 +185	+21%	+$26.3K	0.02%	101
2013 Q2	$138K	Buy	+882	New	+$132K	0.05%	118

Other funds holding TDG

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Howard Hughes Medical Institute's TDG Position: Q1 2026 in Review

Howard Hughes Medical Institute sold out of TransDigm Group (TDG) in Q1 2026, closing a stake of 12 shares — an estimated $16K sold.

Howard Hughes Medical Institute first reported a position in TDG in Q2 2013 and held it in 11 quarters. The position peaked at $437K in Q2 2016. 1,108 funds tracked by Wall St. Rank hold TDG as of Q1 2026.

Howard Hughes Medical Institute reported no remaining TransDigm Group position as of Q1 2026 after selling out during the quarter.
Howard Hughes Medical Institute sold 12 TransDigm Group shares in Q1 2026, an estimated $16K.
Howard Hughes Medical Institute first reported a position in TransDigm Group in Q2 2013 and held it in 11 quarters.
Howard Hughes Medical Institute's TransDigm Group position peaked at $437K in Q2 2016.
1,108 funds tracked by Wall St. Rank held TransDigm Group as of Q1 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q1 2026, filed 15 May 2026.